tbuckley/cabot-search huggingface dataset:
Medical Debt in the US From 2009 to 2020—Reply
Authors: Neale Mahoney, Francis Wong, Wesley Yin
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TWO-YEAR OUTCOMES OF QUANTITATIVE FLOW RATIO-GUIDED CORONARY REVASCULARIZATION FOR PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING PRIMARY VALVE SURGERY (QVAS-PILOT STUDY)
Authors: Yunpeng Zhu, Jiaxi Zhu, Anqing Chen, Zhe Wang, Jun Liu, Mi Zhou, Xiaofeng Ye, Wei Zhang, Shengxian Tu, Qiang Zhao
Journal: Journal of the American College of Cardiology (2021)
Lysosomal Acid Lipase a (LIPA) Modulates Leukemia Stem Cell (LSC) Response to Venetoclax/TKI Combination Therapy in Blast Phase Chronic Myeloid Leukemia
Authors: Mohd Minhajuddin, Haobin Ye, Amanda C. Winters, Shanshan Pei, Nabilah Khan, Brett M. Stevens, Biniam Adane, Maria L. Amaya, Anagha Inguva, Anna Krug, Maura Gasparetto, Daniel W. Sherbenou, Daniel A. Pollyea, Clayton Smith, Craig T. Jordan
Journal: Blood (2021)
Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)
Authors: Henry Idrobo, Denisse Castro, Lorena Fiad, Yesenia M. Huerta- Collado, Victoria Otero, Sally Rose Paredes, Juan Esteban Garcia-Robledo, Juan Felipe Lasso, Humberto Martinez-Cordero, Ana Maria Osorio-Gomez, Julian Andres Sanchez-Perea, Bryan Valcarcel, Luis Villela, Marialejandra Alejandra Torres Viera, Brady E Beltran, Jorge J. Castillo, Luis Malpica-Castillo
Journal: Blood (2021)
Intravenous Immunoglobulin in the Management of Severe Early Onset Red Blood Cell Alloimmunization
Authors: Evangelia Vlachodimtropoulou Koumoutsea, Tsz Kin Lo, Clarissa Bambao, Greg Denomme, Gareth Seaward, Rory Windrim, Francine Tessier, Edmond Kelly, Nimrah Abbasi, Greg Ryan
Journal: Blood (2021)
SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes
Authors: Jacob G Ludington, Shabbir A Ansari, Alec A Schmaier, Keiichi Enjyoji, Benjamin E Nilsson-Payant, Yaron Bram, Vasuretha Chandar, Alain Borczuk, Benjamin R tenOever, Robert E Schwartz, Sol Schulman
Journal: Blood (2021)
Female gender is associated with long COVID syndrome: a prospective cohort study
Authors: Francesca Bai, Daniele Tomasoni, Camilla Falcinella, Diletta Barbanotti, Roberto Castoldi, Giovanni Mulè, Matteo Augello, Debora Mondatore, Marina Allegrini, Andrea Cona, Daniele Tesoro, Gianmarco Tagliaferri, Ottavia Viganò, Elisa Suardi, Camilla Tincati, Tomaso Beringheli, Benedetta Varisco, Chiara Luridiana Battistini, Kyrie Piscopo, Elena Vegni, Alessandro Tavelli, Stefano Terzoni, Giulia Marchetti, Antonella d’Arminio Monforte
Journal: Clinical Microbiology and Infection (2021)
Beyond building back better: imagining a future for human and planetary health
Authors: Emilia Aragón de León, Amanda Shriwise, GÖran Tomson, Stephen Morton, Diogo Simão Lemos, Bettina Menne, Mark Dooris
Journal: The Lancet Planetary Health (2021)

COVID-19 is disrupting and transforming the world. We argue that transformations catalysed by this pandemic should be used to improve human and planetary health and wellbeing. This paradigm shift requires decision makers and policy makers to go beyond building back better, by nesting the economic domain of sustainable development within social and environmental domains. Drawing on the engage, assess, align, accelerate, and account (E4As) approach to implementing the 2030 Agenda for Sustainable Development, we explore the implications of this kind of radical transformative change, focusing particularly on the role of the health sector. We conclude that a recovery and transition from the COVID-19 pandemic that delivers the future humanity wants and needs requires more than a technical understanding of the transformation at hand. It also requires commitment and courage from leaders and policy makers to challenge dominant constructs and to work towards a truly thriving, equitable, and sustainable future to create a world where economic development is not an end goal itself, but a means to secure the health and wellbeing of people and the planet.
Transplant Outcomes in Patients with Ph+ Chronic Myeloid Leukemia: Haploidentical Donors Compared to Matched Sibling Donors and Matched/Mismatched Unrelated Donors: A Retrospective Analysis from the EBMT Chronic Malignancies Working Party (EBMT-CMWP)
Authors: Francesco Onida, Ge Junran, Linda Koster, Rose-Marie Hamladji, Jennifer Byrne, Victoria Potter, Mahmoud Aljurf, Marie Robin, Kazimierz Halaburda, Jakob R. Passweg, Urpu Salmenniemi, Henrik Sengeloev, Jane F Apperley, Andrew Clark, Péter Reményi, Elena V. Morozova, Charles Craddock, Stig Lenhoff, Arnold Ganser, Ka Lung Wu, Antonio Perez Martinez, Patrick John Hayden, Luuk Gras, Yves Chalandon, Ibrahim Yakoub-Agha
Journal: Blood (2021)
The Two-Step Approach to Haploidentical Transplant: Can Altering Timing in the Conditioning Regimen Increase Graft Versus Tumor Effects?
Authors: Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, Shannon Rudolph, John L. Wagner, Usama Gergis, Neal Flomenberg
Journal: Blood (2021)
Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Authors: Yue Wei, Hong Zheng, Pamela Lockyer, Naran Bao, Faezeh Darbaniyan, Ziyi Li, Rashmi Kanagal-Shamanna, Kelly A. Soltysiak, Hui Yang, Irene Ganan-Gomez, Kim-Anh Do, Simona Colla, Kelly S. Chien, Guillermo Montalban-Bravo, Naval Daver, Guillermo Garcia-Manero
Journal: Blood (2021)
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling (vol 13, 58, 2021)
Authors: Bing Yao, Tao Gui, Xiangwei Zeng, Yexuan Deng, Zhi Wang, Ying Wang, Dongjun Yang, Qixiang Li, Peipei Xu, Ruifeng Hu, Xinyu Li, Bing Chen, Jin Wang, Ke Zen, Haitao Li, Melissa J Davis, Marco J Herold, Hua-Feng Pan, Zhi-Wei Jiang, David Cs Huang, Ming Liu, Junyi Ju, Quan Zhao
Journal: Genome Medicine (2021)
BRUIN CLL-322: A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)
Authors: Anthony R. Mato, William G. Wierda, John M. Pagel, Matthew S. Davids, Pier Luigi Zinzani, Yi Lu, Hui Liu, Safi Shahda, Ching Ching Leow, Constantine S. Tam, Jennifer A. Woyach, Toby A. Eyre
Journal: Blood (2021)
The transcription factor EGR2 is indispensable for tissue-specific imprinting of alveolar macrophages in health and tissue repair
Authors: Jack McCowan, Frédéric Fercoq, Phoebe M. Kirkwood, Wouter T’Jonck, Lizi M. Hegarty, Connar M. Mawer, Richard Cunningham, Ananda S. Mirchandani, Anna Hoy, Duncan C. Humphries, Gareth-Rhys Jones, Carsten G. Hansen, Nik Hirani, Stephen J. Jenkins, Sandrine Henri, Bernard Malissen, Sarah R. Walmsley, David H. Dockrell, Philippa T. K. Saunders, Leo M. Carlin, Calum C. Bain
Journal: Science Immunology (2021)

EGR2 controls alveolar macrophage function in health and disease.
Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia
Authors: Huafeng Wang, Jiejing Qian, Chang Yang, Yi Zhang, Yungui Wang, Ting Shi, Yongxian HU, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu
Journal: Blood (2021)
Electrodiagnostic Testing for Diagnosing Polyneuropathy
Authors: Ryan D. Jacobson, Michelle Glantz
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease
Authors: Nkiruka V. Arinze, Wenqing Yin, Saran Lotfollahzadeh, Marc Arthur Napoleon, Sean Richards, Joshua A. Walker, Mostafa Belghasem, Jonathan D. Ravid, Mohamed Hassan Kamel, Stephen A. Whelan, Norman Lee, Jeffrey J. Siracuse, Stephan Anderson, Alik Farber, David Sherr, Jean Francis, Naomi M. Hamburg, Nader Rahimi, Vipul C. Chitalia
Journal: Journal of Clinical Investigation (2021)

Chronic kidney disease (CKD) imposes a strong and independent risk for peripheral artery disease (PAD). While solutes retained in CKD patients (uremic solutes) inflict vascular damage, their role in PAD remains elusive. Here, we show that the dietary tryptophan-derived uremic solutes including indoxyl sulfate (IS) and kynurenine (Kyn) at concentrations corresponding to those in CKD patients suppress β-catenin in several cell types, including microvascular endothelial cells (ECs), inhibiting Wnt activity and proangiogenic Wnt targets in ECs. Mechanistic probing revealed that these uremic solutes downregulated β-catenin in a manner dependent on serine 33 in its degron motif and through the aryl hydrocarbon receptor (AHR). Hindlimb ischemia in adenine-induced CKD and IS solute-specific mouse models showed diminished β-catenin and VEGF-A in the capillaries and reduced capillary density, which correlated inversely with blood levels of IS and Kyn and AHR activity in ECs. An AHR inhibitor treatment normalized postischemic angiogenic response in CKD mice to a non-CKD level. In a prospective cohort of PAD patients, plasma levels of tryptophan metabolites and plasma's AHR-inducing activity in ECs significantly increased the risk of future adverse limb events. This work uncovers the tryptophan metabolite/AHR/β-catenin axis as a mediator of microvascular rarefaction in CKD patients and demonstrates its targetability for PAD in CKD models.
Leveraging Pathway-Interference to Overcome Drug-Resistance in Acute Lymphoblastic Leukemia
Authors: Lai N. Chan, Mark A. Murakami, Christian Hurtz, Kohei Kume, Jaewoong Lee, Kadriye Nehir Cosgun, Huimin Geng, Shai Izraeli, David M. Weinstock, Markus Müschen
Journal: Blood (2021)
Long-Term Survival and Late Death after Hematopoietic Cell Transplant for Patients with Sickle Cell Disease Surviving for at Least Two-Years after Transplantation
Authors: Andrew St. Martin, Kyle Hebert, Arnaud Serret-Larmande, Vianney Jouhet, Emily Hughes, Jason Paul Stedman, Thomas DeSain, Danielle Pillon, Jessica Lyons Carpenter, Patricia Steinert, Paul Avillach, Mary Eapen
Journal: Blood (2021)
Abstract 9362: A Quality Improvement Project to Optimize TEE Orders and Reduce Hospitalization Cost at a Large Volume Academic Hospital
Authors: Malak Modi, Ali Sultan, Desiree Dawson, Kendall Douglass, Kalgi A Modi
Journal: Circulation (2021)

Introduction: Appropriate use criteria (AUC) for indication of transesophageal echocardiography (TEE) were revised in 2011. Aim: To evaluate the appropriateness of TEEs ordered at Ochsner LSU Health Shreveport based on 2011 AUC guidelines and take necessary steps to optimize the TEE workflow and reduce hospitalization cost. Method: A retrospective analysis of the TEE case requests received by the echocardiography lab at Ochsner LSU Health Shreveport between March 1, 2020 and August 31, 2020 was carried out. Each TEE case request was classified as appropriate (A), inappropriate (I) or uncertain (U) based on the 2011 AUC guideline. TEE case requests were divided based on the ordering specialty as well as indications. Result: Among the total 372 case requests for TEE,189 (50.80%) were ordered by cardiologists and 183 (49.20%) were ordered by non-cardiologists. Out of the 189 orders by cardiologists, 184 (97.35%) were appropriate and 5 (2.65%) were inappropriate. Cardiologists ordered 123 TEEs for Atrial fibrillation/flutter evaluation/management, 33 for valvular evaluation, 10 for evaluation of mass/vegetation, 3 for atrial mass evaluation, 10 for CVA workup and 10 for other reasons. Among the total 183 TEE orders placed by non-cardiologists, 125 (68.31%) were appropriate and 58 (31.69%) were inappropriate. Specialty-wise, Neurology placed 78 TEE orders (54-A, 24-I), Hospital Medicine placed 59 orders (38-A, 21-I) while other specialties placed 46 orders (33-A, 13-I). Most common indications for TEE requests by non-cardiologists were for CVA workup (62-A, 30-I) and infective endocarditis workup (21-A, 13-I). Conclusion: 83% of all the TEE orders (309 out of 372) were appropriate. 97% (184 from 189) of the TEE orders by cardiologists were appropriate compared to 68% (125 from 183) orders by non-cardiologists. Following this result, medical providers were educated about the correct indications of TEE by educational presentation as well as distributing posters and pocket cards. Plan is to also evaluate the appropriateness of TEE orders post intervention phase. We believe that educating the physician providers can optimize the appropriate TEE requests, avoid unnecessary invasive procedures and reduce the hospitalization cost.
Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression <i>in Vitro</i>
Authors: Manja Wobus, Ekaterina Balaian, Uta Oelschlaegel, Russell Towers, Kristin Möbus, Ivonne Habermann, Rebekka Wehner, Friedrich Stölzel, Triantafyllos Chavakis, Marie Törngren, Helena Eriksson, Uwe Platzbecker, Christoph Röllig, Martin Bornhäuser, Katja Sockel
Journal: Blood (2021)
Nonmyeloablative HLA-Identical Sibling Donor Transplantation for Children and Young Adults with Sickle Cell Disease: Interim Results of the SUN Multicenter Phase II Trial
Authors: Robert Sheppard Nickel, KY Chiang, Steven J. Hardy, Hemalatha G Rangarajan, Sonali Chaudhury, Michael Kent, Monica Bhatia, Jeremy Zack, Vivitha Mani, Gregory M.T. Guilcher, Allistair Abraham
Journal: Blood (2021)
Fake covid vaccines boost the black market for counterfeit medicines
Authors: Kanchan Srivastava
Journal: BMJ (2021)

Counterfeit medicines and vaccines have always threatened public health, but the pandemic has brought a global surge in black market sales, writes Kanchan Srivastava When the World Health Organization flagged the danger of fake covid-19 vaccines in August,1 Mumbai and Kolkata police were already prosecuting a dozen people for their alleged involvement in "fake vaccination drives" conducted in May and June. In Kolkata, a member of parliament, Mimi Chakraborty, was among 500 people administered fake versions of Covishield (India's version of the AstraZeneca vaccine). China has been clamping down on counterfeit versions of its domestically produced vaccines,2 while Mexico and Poland have reported counterfeits of Pfizer vaccines being given to people for $1000 each.3 Mexican customs officials have also seized vials of fake Sputnik V vaccine destined for Honduras.4 An Interpol operation across southern Africa in July and August led to the identification of 179 suspects and the seizure of $3.5m worth of goods, including vaccines, face masks, and fake covid-19 test certificates.5 "I've never seen such a dynamic situation before," Jürgen Stock, general secretary of Interpol, told Time magazine,6 "The liquid gold in 2021 is the vaccine, and already we are seeing that vaccine supply chains are targeted more and more [by counterfeiters]." ### What is a fake medicine? Interpol defines a counterfeit or substandard medicine as one that differs from the authentic version of the vaccine by:
Abstract 11319: Success and Complication Rates in Cardiac Implantable Electronic Device (CIED) Laser Lead Extractions: A Systematic Review
Authors: Josh E Herman, Deborah Somanader, Laith Ishaq, Ahmed Abdelaal, Rayoun Ramendra, Vrati Mehra, Andrew Morris
Journal: Circulation (2021)

Introduction: Laser extraction sheaths are a valuable tool for complex CIED lead extractions. While there is evidence to suggest they have a higher complication rate than simple traction, there has been no systematic review of the literature regarding the success and complication rate associated with laser lead extractions. Objective: To conduct a systematic review investigating success and complication rates of CIED lead extractions using laser sheaths. Methods: A search was performed of studies published between January 1, 2000-August 29, 2019 indexed on Medline, EMBASE and Cochrane. Inclusion criteria were: (a) transvenous removal of ICD, pacemaker or CRT device leads, (b) Age≥18, (c) n&gt;100 patients. Exclusion criteria were: (a) generator only procedures, (b) planned surgical extractions, (c) data prior to 2000. From these studies, we further selected papers containing laser lead extractions only, or laser-only cohorts, that reported on our outcomes. Outcomes: Complete procedural success, major and minor complications and procedure-related mortality. Results: 2307 abstracts were screened after de-duplication resulting in 164 papers. Of these papers, 11 were selected based on our inclusion criteria. All included studies follow the Heart Rhythm Society 2009 and 2017 or North American Society of Pacing and Electrophysiology 2000 guidelines criteria for extraction, major complications, minor complications and procedural success. Complete procedural success was reported by 9 studies which ranged from 89.26-100%; median 93.5% (IQR 89.26-97.56%). All 11 studies reported major complications which ranged between 1.08-6.25%; median 1.98% (IQR 1.50-3.57%). 8 reported minor complications which ranged from 1.09-5.69%; median 4.52% (IQR 3.80-4.94%). Procedure-related mortality was reported by 10 studies which ranged from 0-2.68%; median 0.10% (IQR 0.00-0.48%), while all-cause mortality during hospitalization was reported by 7 studies ranging from 0-2.17%; median 0.23% (IQR 0.00-1.18%). Conclusion: Laser lead extraction is associated with a high success rate of complete removal. Mortality rates due to procedure related factors are very low, however major and minor complications are not uncommon.
Will New Approaches in The Treatment of Supraventricular Tachycardia Affect The Cardiologists’ Perspective?
Authors: Cetin Sanlialp Sara
Journal: Clinical Cardiology and Cardiovascular Interventions (2019)

Junctional ectopic tachycardia(JET) is one of the rare supraventricular arrhythmias(1). JET is categorized by two types. The less common type of JET is congenital form and the more common type has been seen in postoperative period of congenital cardiac surgery
The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
Authors: Andrea C. Lo, Amy Liu, Qi Liu, Yutaka Yasui, Sharon M. Castellino, Kara M. Kelly, Alex F. Herrera, Jonathan W. Friedberg, Debra L. Friedman, Cindy L. Schwartz, Samuel Bergeron-Gravel, Hitesh Dama, Kenneth B. Roberts, Louis S. Constine, David Hodgson
Journal: Blood (2021)
Changing face of ectopic pregnancy
Authors: M. R Gazvani, I. Aird, S. J Wood, A. J M Thomson, C. R Kingsland, M. Sowter, C. Farquhar
Journal: BMJ (1997)

More widespread public debate on rationing is essentialEditor-We find it significant that none of the clinicians who contributed to the conference "Rationing in the NHS: Time to Get Real" signed the open letter to Frank Dobson. 1 In the letter, rationing is defined as occurring when not all health services can be provided to everybody who might benefit from them, a definition so broad that it can be said always to have existed.Yet most British clinicians would not recognise the examples given as rationing.A young woman with high cholesterol as a single risk factor for coronary heart disease may be "denied" drug treatment and given dietary advice instead simply because the risks of side effects outweigh the marginal benefit; this is rational, not rationing.Again, "denying" magnetic resonance imaging for uncomplicated migraine in a young person has nothing to do with cost: the risks of iatrogenic anxiety and distress are far greater than any possible benefit from such intervention.The authors do the cause of so called smart rationing a disservice by these examples.This debate is too important to be "dumbed down" in this way.Whenever rationing is discussed there is a tension between those whose professional discipline (health economics, medical ethics, or policy analysis) allows them to work with broad underlying principles and those who are constantly brought face to face with the limitations of these principles through daily contact with patients.The former are much more likely to believe that it is possible and appropriate to base all rationing decisions on a series of well argued principles.Life for the latter is far messier: it is often impossible to apply broad principle to individual cases, let alone find a "currency of comparison" 2 that will enable the claims of, for example, a dying older person on an understaffed geriatric ward to be ranked against those of a patient with multiple sclerosis who might benefit from interferon beta.Struggling to make these sorts of comparisons is painful; the examples given in the open letter tax no one and thereby offer false hope of easy solutions.It is because the choices are difficult that more widespread public debate is essential.Only through such a debate can we all, as citizens, realise what is happening to the NHS, consider if that is the NHS that we want, and decide how much of our taxes an NHS worthy of the name deserves.
Safety and Cost Effectiveness of Chimeric Antigen Receptor T Cell Therapy in the Outpatient Setting
Authors: Moazzam Shahzad, Muhammad Salman Faisal, Ernie Shippey, Ali Hussain, Clint Divine, Zahra Mahmoudjafari, Allison Appenfeller, Muhammad Umair Mushtaq, Leyla Shune, Joseph P. McGuirk, Nausheen Ahmed
Journal: Blood (2021)